New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients
Links shared publicly online about this topic.
- 151total visits
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients
Eisai Europe Ltd, a subsidiary of Eisai Co., Ltd (Headquarters: Tokyo; President and CEO: Haruo Naito), today announced the results from a new Phase III study (E2090-E044-310 Monotherapy Study) wh
View full resource at medicalnewstoday.com
Tags: Seizure, Epilepsy, Eisai
Most Recently Shared on July 13, 2011 at 5:50 am By:
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients: Eisai Eu... http://bit.ly/qoW70N
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients
medicalnewstoday.com — “Eisai Europe Ltd, a subsidiary of Eisai Co., Ltd (Headquarters: Tokyo; President and CEO: Haruo Naito), today announced the results from a new Phase III study (E2090-E044-310 Monotherapy Study) wh” View full resource at medicalnewstoday.com
Most Recently Shared on July 13, 2011 at 3:21 am By:
Danielle M.Rocheford Patient Expert
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients: Eisai Eu... http://bit.ly/oEtp4X
Advertisement
